Digestibility of Different Plant-based Proteins in Humans With Ileostomy (PAN-Prodig)

April 2, 2024 updated by: Örebro University, Sweden

True Ileal Digestibility of Different Plant-based Proteins in a Human Ileostomy Model

The goal of this interventional study is to learn about the digestibility of different plant-based proteins in adults (age 18-75) with an ileostomy.

The main questions the study aims to answer are:

  1. How does the digestibility of proteins in the small intestine differ between different plant-based proteins?
  2. Which proteins and amino acids are not digested or absorbed in the small intestine and are available for further metabolic processes in the large intestine?
  3. How do metabolites in the collected content of the ileostomy bag differ after consuming different plant-based proteins?
  4. Can the in vivo results be compared to results from existing in vitro models?

Participants will consume five different protein meals (oat protein - high bioavailable, oat protein - low bioavailable, pea protein - high bioavailable, pea protein low bioavailable, protein-free meal) on five different study days in a random order. Five hours after consuming the test meals ileostomy bags will be collected and the content will be analysed to answer the above mentioned research questions.

Study Overview

Study Type

Interventional

Enrollment (Estimated)

11

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

      • Örebro, Sweden, 70182
        • Recruiting
        • Örebro University
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Age: 18 - 75 years
  • Body mass index: 18.5 - 30 kg/m2
  • (double-loop) Ileostomy with an intact small bowel
  • Signed informed consent

Exclusion Criteria:

  • Pregnancy or breastfeeding
  • Ileostomy < 3 months before the study
  • Any clinically significant present or past disease/condition other than colon cancer which in the investigator's opinion could interfere with the results of the trial
  • Any clinically significant present or past medication which in the investigator's opinion could interfere with the results of the trial

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Basic Science
  • Allocation: Randomized
  • Interventional Model: Crossover Assignment
  • Masking: Triple

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Dietary Intervention Sequence 1 (Meals: Pea protein (2x), Oat protein (2x), Protein-free (1x))

The participant will consume the below mentioned meals in a random order on five different study days (one on each visit):

  • Protein meal: pea protein, low bioavailability
  • Protein meal: pea protein, high bioavailability
  • Protein meal: oat protein, low bioavailability
  • Protein meal: oat protein, high bioavailability
  • Protein-free meal
Participants will consume a protein meal consisting of cooked whole oat kernels (amount based on body weight, 0.3g of protein/kg bodyweight).
Participants will consume a protein meal consisting of heated oat protein concentrate (amount based on body weight, 0.3g of protein/kg bodyweight).
Participants will consume a protein meal consisting of cooked whole yellow peas (amount based on body weight, 0.3g of protein/kg bodyweight).
Participants will consume a protein meal consisting of heated pea protein isolate (amount based on body weight, 0.3g of protein/kg bodyweight).
Participants will consume a protein-free meal to correct analyses for endogenous protein losses.
Experimental: Dietary Intervention Sequence 2 (Meals: Pea protein (2x), Oat protein (2x), Protein-free (1x))

The participant will consume the below mentioned meals in a random order on five different study days (one on each visit):

  • Protein meal: pea protein, low bioavailability
  • Protein meal: pea protein, high bioavailability
  • Protein meal: oat protein, low bioavailability
  • Protein meal: oat protein, high bioavailability
  • Protein-free meal
Participants will consume a protein meal consisting of cooked whole oat kernels (amount based on body weight, 0.3g of protein/kg bodyweight).
Participants will consume a protein meal consisting of heated oat protein concentrate (amount based on body weight, 0.3g of protein/kg bodyweight).
Participants will consume a protein meal consisting of cooked whole yellow peas (amount based on body weight, 0.3g of protein/kg bodyweight).
Participants will consume a protein meal consisting of heated pea protein isolate (amount based on body weight, 0.3g of protein/kg bodyweight).
Participants will consume a protein-free meal to correct analyses for endogenous protein losses.
Experimental: Dietary Intervention Sequence 3 (Meals: Pea protein (2x), Oat protein (2x), Protein-free (1x))

The participant will consume the below mentioned meals in a random order on five different study days (one on each visit):

  • Protein meal: pea protein, low bioavailability
  • Protein meal: pea protein, high bioavailability
  • Protein meal: oat protein, low bioavailability
  • Protein meal: oat protein, high bioavailability
  • Protein-free meal
Participants will consume a protein meal consisting of cooked whole oat kernels (amount based on body weight, 0.3g of protein/kg bodyweight).
Participants will consume a protein meal consisting of heated oat protein concentrate (amount based on body weight, 0.3g of protein/kg bodyweight).
Participants will consume a protein meal consisting of cooked whole yellow peas (amount based on body weight, 0.3g of protein/kg bodyweight).
Participants will consume a protein meal consisting of heated pea protein isolate (amount based on body weight, 0.3g of protein/kg bodyweight).
Participants will consume a protein-free meal to correct analyses for endogenous protein losses.
Experimental: Dietary Intervention Sequence 4 (Meals: Pea protein (2x), Oat protein (2x), Protein-free (1x))

The participant will consume the below mentioned meals in a random order on five different study days (one on each visit):

  • Protein meal: pea protein, low bioavailability
  • Protein meal: pea protein, high bioavailability
  • Protein meal: oat protein, low bioavailability
  • Protein meal: oat protein, high bioavailability
  • Protein-free meal
Participants will consume a protein meal consisting of cooked whole oat kernels (amount based on body weight, 0.3g of protein/kg bodyweight).
Participants will consume a protein meal consisting of heated oat protein concentrate (amount based on body weight, 0.3g of protein/kg bodyweight).
Participants will consume a protein meal consisting of cooked whole yellow peas (amount based on body weight, 0.3g of protein/kg bodyweight).
Participants will consume a protein meal consisting of heated pea protein isolate (amount based on body weight, 0.3g of protein/kg bodyweight).
Participants will consume a protein-free meal to correct analyses for endogenous protein losses.
Experimental: Dietary Intervention Sequence 5 (Meals: Pea protein (2x), Oat protein (2x), Protein-free (1x))

The participant will consume the below mentioned meals in a random order on five different study days (one on each visit):

  • Protein meal: pea protein, low bioavailability
  • Protein meal: pea protein, high bioavailability
  • Protein meal: oat protein, low bioavailability
  • Protein meal: oat protein, high bioavailability
  • Protein-free meal
Participants will consume a protein meal consisting of cooked whole oat kernels (amount based on body weight, 0.3g of protein/kg bodyweight).
Participants will consume a protein meal consisting of heated oat protein concentrate (amount based on body weight, 0.3g of protein/kg bodyweight).
Participants will consume a protein meal consisting of cooked whole yellow peas (amount based on body weight, 0.3g of protein/kg bodyweight).
Participants will consume a protein meal consisting of heated pea protein isolate (amount based on body weight, 0.3g of protein/kg bodyweight).
Participants will consume a protein-free meal to correct analyses for endogenous protein losses.
Experimental: Dietary Intervention Sequence 6 (Meals: Pea protein (2x), Oat protein (2x), Protein-free (1x))

The participant will consume the below mentioned meals in a random order on five different study days (one on each visit):

  • Protein meal: pea protein, low bioavailability
  • Protein meal: pea protein, high bioavailability
  • Protein meal: oat protein, low bioavailability
  • Protein meal: oat protein, high bioavailability
  • Protein-free meal
Participants will consume a protein meal consisting of cooked whole oat kernels (amount based on body weight, 0.3g of protein/kg bodyweight).
Participants will consume a protein meal consisting of heated oat protein concentrate (amount based on body weight, 0.3g of protein/kg bodyweight).
Participants will consume a protein meal consisting of cooked whole yellow peas (amount based on body weight, 0.3g of protein/kg bodyweight).
Participants will consume a protein meal consisting of heated pea protein isolate (amount based on body weight, 0.3g of protein/kg bodyweight).
Participants will consume a protein-free meal to correct analyses for endogenous protein losses.
Experimental: Dietary Intervention Sequence 7 (Meals: Pea protein (2x), Oat protein (2x), Protein-free (1x))

The participant will consume the below mentioned meals in a random order on five different study days (one on each visit):

  • Protein meal: pea protein, low bioavailability
  • Protein meal: pea protein, high bioavailability
  • Protein meal: oat protein, low bioavailability
  • Protein meal: oat protein, high bioavailability
  • Protein-free meal
Participants will consume a protein meal consisting of cooked whole oat kernels (amount based on body weight, 0.3g of protein/kg bodyweight).
Participants will consume a protein meal consisting of heated oat protein concentrate (amount based on body weight, 0.3g of protein/kg bodyweight).
Participants will consume a protein meal consisting of cooked whole yellow peas (amount based on body weight, 0.3g of protein/kg bodyweight).
Participants will consume a protein meal consisting of heated pea protein isolate (amount based on body weight, 0.3g of protein/kg bodyweight).
Participants will consume a protein-free meal to correct analyses for endogenous protein losses.
Experimental: Dietary Intervention Sequence 8 (Meals: Pea protein (2x), Oat protein (2x), Protein-free (1x))

The participant will consume the below mentioned meals in a random order on five different study days (one on each visit):

  • Protein meal: pea protein, low bioavailability
  • Protein meal: pea protein, high bioavailability
  • Protein meal: oat protein, low bioavailability
  • Protein meal: oat protein, high bioavailability
  • Protein-free meal
Participants will consume a protein meal consisting of cooked whole oat kernels (amount based on body weight, 0.3g of protein/kg bodyweight).
Participants will consume a protein meal consisting of heated oat protein concentrate (amount based on body weight, 0.3g of protein/kg bodyweight).
Participants will consume a protein meal consisting of cooked whole yellow peas (amount based on body weight, 0.3g of protein/kg bodyweight).
Participants will consume a protein meal consisting of heated pea protein isolate (amount based on body weight, 0.3g of protein/kg bodyweight).
Participants will consume a protein-free meal to correct analyses for endogenous protein losses.
Experimental: Dietary Intervention Sequence 9 (Meals: Pea protein (2x), Oat protein (2x), Protein-free (1x))

The participant will consume the below mentioned meals in a random order on five different study days (one on each visit):

  • Protein meal: pea protein, low bioavailability
  • Protein meal: pea protein, high bioavailability
  • Protein meal: oat protein, low bioavailability
  • Protein meal: oat protein, high bioavailability
  • Protein-free meal
Participants will consume a protein meal consisting of cooked whole oat kernels (amount based on body weight, 0.3g of protein/kg bodyweight).
Participants will consume a protein meal consisting of heated oat protein concentrate (amount based on body weight, 0.3g of protein/kg bodyweight).
Participants will consume a protein meal consisting of cooked whole yellow peas (amount based on body weight, 0.3g of protein/kg bodyweight).
Participants will consume a protein meal consisting of heated pea protein isolate (amount based on body weight, 0.3g of protein/kg bodyweight).
Participants will consume a protein-free meal to correct analyses for endogenous protein losses.
Experimental: Dietary Intervention Sequence 10 (Meals: Pea protein (2x), Oat protein (2x), Protein-free (1x))

The participant will consume the below mentioned meals in a random order on five different study days (one on each visit):

  • Protein meal: pea protein, low bioavailability
  • Protein meal: pea protein, high bioavailability
  • Protein meal: oat protein, low bioavailability
  • Protein meal: oat protein, high bioavailability
  • Protein-free meal
Participants will consume a protein meal consisting of cooked whole oat kernels (amount based on body weight, 0.3g of protein/kg bodyweight).
Participants will consume a protein meal consisting of heated oat protein concentrate (amount based on body weight, 0.3g of protein/kg bodyweight).
Participants will consume a protein meal consisting of cooked whole yellow peas (amount based on body weight, 0.3g of protein/kg bodyweight).
Participants will consume a protein meal consisting of heated pea protein isolate (amount based on body weight, 0.3g of protein/kg bodyweight).
Participants will consume a protein-free meal to correct analyses for endogenous protein losses.
Experimental: Dietary Intervention Sequence 11 (Meals: Pea protein (2x), Oat protein (2x), Protein-free (1x))

The participant will consume the below mentioned meals in a random order on five different study days (one on each visit):

  • Protein meal: pea protein, low bioavailability
  • Protein meal: pea protein, high bioavailability
  • Protein meal: oat protein, low bioavailability
  • Protein meal: oat protein, high bioavailability
  • Protein-free meal
Participants will consume a protein meal consisting of cooked whole oat kernels (amount based on body weight, 0.3g of protein/kg bodyweight).
Participants will consume a protein meal consisting of heated oat protein concentrate (amount based on body weight, 0.3g of protein/kg bodyweight).
Participants will consume a protein meal consisting of cooked whole yellow peas (amount based on body weight, 0.3g of protein/kg bodyweight).
Participants will consume a protein meal consisting of heated pea protein isolate (amount based on body weight, 0.3g of protein/kg bodyweight).
Participants will consume a protein-free meal to correct analyses for endogenous protein losses.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
True ileal digestibility of different plant-based proteins
Time Frame: 0-5 hours after consumption of test meal (on all 5 study days)
The primary outcome is defined as the differences in the true ileal digestibility, determined by measuring the amount of nitrogen in the meal and the amount of unabsorbed nitrogen in the ileal fluid after consuming four different plant-based protein meals
0-5 hours after consumption of test meal (on all 5 study days)

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Protein and metabolite profiles in ileostomy digesta
Time Frame: 0-5 hours after consumption of test meal (on all 5 study days)
The secondary outcomes are defined as changes in protein and metabolite profiles in the digesta, determined by proteomics and metabolomic analyses.
0-5 hours after consumption of test meal (on all 5 study days)
Differences between in vivo and in vitro data
Time Frame: In vivo data: 0-5 hours after consumption of test meal (on all 5 study days)
Results from the human ileostomy model will be compared with results from in vitro digestion according to the Infogest 2.0 protocol for each of the tested plant-based proteins
In vivo data: 0-5 hours after consumption of test meal (on all 5 study days)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

April 1, 2024

Primary Completion (Estimated)

December 1, 2024

Study Completion (Estimated)

December 1, 2024

Study Registration Dates

First Submitted

November 15, 2023

First Submitted That Met QC Criteria

November 15, 2023

First Posted (Actual)

November 21, 2023

Study Record Updates

Last Update Posted (Actual)

April 3, 2024

Last Update Submitted That Met QC Criteria

April 2, 2024

Last Verified

April 1, 2024

More Information

Terms related to this study

Other Study ID Numbers

  • Dnr 2023-04189-01

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Ileostomy - Stoma

Clinical Trials on Oat Protein, low bioavailability

3
Subscribe